Biomedical, Clinical & Life Sciences

Request Ticket // Limit: 1 // Tickets Available: 1

These grants are not for a specific research project, but rather for personnel (i.e., a clinical research associate) or resources to allow more research to be done. These grants are intended for institutions with the potential to participate significantly more in childhood cancer clinical trials, but which are smaller or have barriers to greater participation due to a lack of resources. Applications to support Clinical Research Associate (CRA) type positions are preferred. Preference is given to institutions with high needs and low philanthropic support in geographical areas where St. Baldrick’s funds are raised. Institutions which do not currently receive other St. Baldrick’s grants are also given preference. (Grant will be $25,000–$50,000.)  

For full eligibility criteria, please see the RFA.

Request Ticket // Limit: 1* // Tickets Available: 1

* ATTENTION: limited submissions policy exception:  Due to high interest from donors and low numbers of past applications, a second Fellow application will be accepted only if focused on one of the following: 

• Brain tumors – all types, including rare forms, especially atypical teratoid/rhabdoid tumor (AT/RT), diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG), and glioblastoma (GBM) 
• Burkitt lymphoma – all types, especially sporadic 
• Rhabdoid tumors - Extrarenal 
   

Fellowship Duration

St. Baldrick’s Fellowships are granted for two (2) years of pediatric oncology fellowship training, with an opportunity for one (1) additional year of funding based upon need, significant accomplishment, and approved application. 

Eligibility 

For full eligibility, please see the RFA.

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

For the V Foundation V Scholar Grant 2025 funding opportunity, the University of Arizona Cancer Center (UACC) can nominate one applicant.

For more information please contact: UACC-PreAward.

Purpose of Award:

The UACC is seeking nominations for the V Scholar Grant call which supports adult cancer research. This award supports tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. Emphasis for this grant mechanism is on supporting exceptional early career investigators at the Assistant Professor stage to be better positioned to leverage large R01 or similar sustaining grants.

Research on ANY adult cancer type will be funded in this call. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Applicant Eligibility:

Nominee must meet all of the following criteria by the nomination due date:

• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• Either a US Citizen or a permanent legal resident in the US.
• Possess at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for their specialty.
• Clinical scientists are eligible if the research institution demonstrates that it will fully support the research applicant (e.g., dedicated lab space, committed research time, start-up funds).
• Must be in a full-time tenure track or tenured faculty position (for e.g., must be eligible to
  apply for PI status on an R01 at your institution). Non-promotable adjunct, affiliated, temporary, part-time, or acting faculty positions are not eligible for Principal Investigator nomination.
• V Scholar applicants must have been appointed to their first full-time tenure track Assistant Professor position no more than 5 years prior to the nomination due date, and not yet promoted to Associate Professor.
  • Extensions to the 5-year limit may be given on a case-by-case basis to nominees who took parental leave (or other types of leave) during this window. Please contact grants@v.org with the following to obtain approval BEFORE submitting the nomination form:
    • Appointment start date
    • Length of leave
    • Institutional tenure clock stoppages/extensions, if applicable

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

For the V Foundation Breast Cancer Research Game-Changer Grant 2025 funding opportunity, the University of Arizona Cancer Center (UACC) can nominate one applicant.

For more information please contact: UACC-PreAward.

Purpose of Award:

This request for applications will support breast cancer research specifically at the University of Arizona Cancer Center. Hooters of America, LLC raised these funds through their local franchisees, for the 2024 “Give A Hoot” in the fight against breast cancer campaign and donated them to the V Foundation to support programs at regional cancer centers for breast cancer research. For these raised funds, the University of Arizona Cancer Center was selected as the designated recipient of regional funds in the amount of $186,000. This request for applications is specifically for Breast Cancer Research.

Applicant Eligibility:

• Nominee must meet all of the following criteria by the nomination due date:
  • Employed at the nominating institution and nominated by their Cancer Center Director or similar high ranking research official.
  • Must be either a US Citizen or have a legal permit (temporary or permanent) to work in the US.
  • Hold a full-time faculty appointment at the Assistant Professor or Assistant Professor-equivalent level or above. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination.
     

Apply to internal competition // Limit: 3* // Tickets Available: 3

The University of Arizona may submit a total of three nominations:

• One from the College of Medicine - Tucson
• One from the College of Medicine - Phoenix 
• One from the College of Nursing

Eligibility:

1. Be a benefits-eligible faculty member in a United States accredited nursing school, allopathic medical school, or osteopathic medical school. Candidates should have approximately three to eight years of faculty experience at the time of application.
2. Be a doctorally prepared faculty member in good standing at the sponsoring school.
3. Be nominated by the dean of the nursing or medical school. There can be only one nominee per nursing or medical school, and a nursing or medical school with a first-year Macy Faculty Scholar is precluded from nominating a candidate.
4. Have an educational scholarship project with the appropriate institutional support.
5. Have a faculty mentor who will advise the candidate on the candidate's educational project and career development.
6. Have an institutional commitment for the protection of 50% of the candidate’s time.
7. Be a citizen or permanent resident of the United States or its territories.

Program Overview

The Macy Faculty Scholars Program, now in its second decade, aims to identify and nurture promising early-career educators in medicine and nursing. The program will help develop the next generation of national leaders in medical and nursing education by identifying outstanding educators, physicians, nurses, and role models—individuals who represent the breadth of diversity seen in learners, patient populations, and health care settings around the country. By providing the Scholars with resources—especially protected time, mentorship, and a professional network of colleagues—the program aims to accelerate Scholars’ careers, to turn their teaching practice into scholarship, and to help them become impactful leaders locally, nationally, and beyond.

This is a career development award. The Foundation is interested in candidates for whom the program will have the maximum impact at this point in their career and who also have the greatest possibility for future impact at their home institutions and beyond. Macy Faculty Scholars will participate in the Macy Faculty Scholars Annual Meeting and will be part of the family of Macy Faculty Scholars for the remainder of their careers.

In order to develop the careers of educators who are future leaders, the Macy Faculty Scholars Program will provide salary support for each Scholar up to $100,000 per year, which will protect 50% of the Scholar’s time over two years. The Scholar will devote this time to a mentored educational scholarly project and other appropriate career development activities.

Limit: 1 LOI per department

V. Lai (Psychology) 

Eligibility
Organizations may submit only one Letter of Inquiry and corresponding proposal per grant cycle. Common exceptions include proposals submitted by separate departments of large universities. 


RRF funds research that seeks to identify interventions, policies and practices to improve the well-being of older adults and/or their caregivers. Preference is given to projects aimed at generating practical knowledge and guidance that can be used by advocates, policy-makers, providers, and the aging network. Of particular interest are:

• Interventional trials; translational studies; and health services and policy research
• Projects that build on the investigator’s past studies
• Proposals that include robust dissemination plans, if appropriate, to assure that findings reach audiences positioned to act on them

Request Ticket // Limit: 2* // Tickets Available: 2

Basic through Pre-clinical Research Studies // Limit: 1 // Tickets Available: 1

Clinical through Public Health Research // Limit: 1 // Tickets Available: 1 

ADA will accept up to two (2) nominations per institution with one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research.

Nominations are welcomed from all areas of diabetes and span prevention, management, and cure of all diabetes types (i.e. type 1, type 2 and gestational), diabetes-related disease states (obesity, prediabetes, and other insulin resistant states) and complications. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics, and physics.

Examples of basic through preclinical research studies (for nomination #1) include:

• Innovative mechanistic studies on fundamental or new aspects of biology
• Novel insights derived from data science using AI/Machine Learning
• Development of new technologies, devices, and/or experimental approaches
• Identification and validation of novel and unique therapeutic targets 

Examples of clinical through public health research (for nomination #2) include:

• Clinical experimental medicine studies
• Identification and validation of novel biomarkers
• Health services research
• Behavioral research
• Population epidemiology
• Health economics research
• Patient preference / Quality of Life
• Dissemination and implementation science

• Health Care system-based interventions

   

Initiator Award Eligibility

• Applicants must currently be in research training positions (i.e. post-doctoral fellowships, research fellowships) and can have no more than seven (7) years of training since their doctoral degree.
• Initiator award recipients cannot concurrently hold an NIH K99/R00 grant. All other Career Development awards are allowable (unless holding of concurrent awards is prohibited by the other granting agency).
• Candidate’s must hold a full-time appointment at their sponsoring institution. Rare exceptions to full- time positions may be granted on a case-by-case basis and must be pre-approved by ADA Research Programs staff prior to application submission.
• Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree.
• Applicant fellowship positions must be at university-affiliated institutions or other non-profit research institutions within the United States and U.S. possessions.
• To assure continued excellence and diversity among applicants and awardees, the Association welcomes applications from all qualified individuals and strongly encourages applications from persons with diverse backgrounds, including minority groups that are underrepresented in biomedical research.
• Individuals must have permission to work within the U.S., either as U.S. citizens or permanent residents, or with appropriate work visas/permits. Institutional confirmation of permission to work within the U.S. will be required at the time of application submission

Limit: 1 // Tickets Available: 0

S. Goldman (Sarver Heart Center)

Program Overview:
The Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research supports research in the area of the prevention of coronary heart disease or circulatory failure and improving care for these patients. The Program focuses on basic and translational scientific research. Clinical studies are currently ineligible.

Action Applications examining the intersection of coronary heart disease and/or congestive heart failure and COVID-19 or similar viral illnesses are highly encouraged to apply.

Eligibility:
In accordance with Mr. Geneen’s directives, the Program supports smaller, mid-sized institutions. Each invited institution may only submit one application from a full-time faculty member. Junior faculty and those with less than $500,000 in direct costs funding at the time of application, are encouraged to apply. United States citizenship is not required.

No Applicants // Limit: 1 // Tickets Available: 1 

The University of Arizona Cancer Center (UACC) can nominate one applicant for the Susan G. Komen Rising Star Researcher Award 2025 which recognizes innovative work, budding leadership and dedicated mentorship in breast cancer research and treatment.

For more information please contact: UACC-PreAward.

Purpose of Award:

This award will honor an investigator whose work has the potential to significantly impact the breast cancer field, who demonstrates strong leadership potential in the breast cancer community and who exhibits a strong commitment to trainee mentorship.

The Rising Star Researcher Award has become another marquee breast cancer research award for Susan G. Komen and complements the Brinker Awards established in 1992 to honor pioneers and distinguished investigators in basic science and clinical research.

The Rising Star Researcher Award will be given annually to:

• a breast cancer researcher from across the continuum of basic, translational, clinical, population health and implementation science research
• who is driving science that is having a substantial impact, expanding our understanding of breast cancer and/or improving breast cancer care and outcomes,
• is beginning to establish visibility and leadership in the field, beyond their scientific and/or clinical discoveries, and
• is demonstrating mentorship that is significantly impacting the education and professional development of research and/or clinical trainees.

No Applicants // Limit: 3* // Tickets Available: 3

*The University of Arizona Cancer Center (UACC) can nominate up to three applicants (one per category) for the Susan G. Komen’s Brinker Awards for Scientific Distinction 2025 which recognizes pioneering work in breast cancer research and treatment. 

For more information please contact: UACC-PreAward.

Award Categories (Limit 1 Each) 

• The Brinker Award for Scientific Distinction in Basic Science will be presented to a basic science and/or translational researcher whose scientific discoveries or novel technologies have substantively impacted our understanding of the basic biology and intrinsic molecular processes driving breast cancer to improve breast cancer care.
• The Brinker Award for Scientific Distinction in Clinical Research will be presented to a clinical researcher who has advanced new approaches for prevention, detection, diagnosis and treatment that have paved the way for new clinical and therapeutic applications and/or practice changing, patient-focused care for breast cancer.
• The Brinker Award for Scientific Distinction in Population Science will be presented to a researcher who has made pivotal advances in implementing science, cancer care delivery, health services research, epidemiology and/or developed innovative evidence-based interventions to enhance breast cancer outcomes.